<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03447457</url>
  </required_header>
  <id_info>
    <org_study_id>FLORAL-ER</org_study_id>
    <nct_id>NCT03447457</nct_id>
  </id_info>
  <brief_title>Early Initiation of High-flow Nasal Cannula Oxygen Therapy in Patients With Acute Respiratory Failure in the Emergency Department: A Before-after Study</brief_title>
  <official_title>Early Initiation of High-flow Nasal Cannula Oxygen Therapy in Patients With Acute Respiratory Failure in the Emergency Department: A Before-after Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CHG de Niort, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the efficiency on respiratory failure regression of
      high-flow nasal oxygen therapy versus standard oxygen in patients admitted to the ED for de
      novo acute respiratory failure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective observational before-after study at the ED in two French centers.

      Selection of patients with acute hypoxemic respiratory failure at the ED.

      Application of oxygen strategy according to the period:

        -  before period: standard oxygen delivered through nasal cannula, face mask or
           non-rebreathing reservoir mask, with a flow rate adjusted to maintain a pulse oxymetry
           of at least 92%.

        -  after period: high-flow oxygen therapy continuously applied via large-bore nasal prongs
           with a gas flow rate of 50 L/min and a FiO2 adjusted to maintain a pulse oxymetry at
           least 92%.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2015</start_date>
  <completion_date type="Actual">May 30, 2017</completion_date>
  <primary_completion_date type="Actual">May 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>FLORAL-ER is a before/after study</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>complete regression of respiratory failure</measure>
    <time_frame>one hour after initiation of oxygen strategies</time_frame>
    <description>respiratory rate less than 25 breaths per minute and regression of signs of increased work of breathing</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Acute Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>standard oxygen group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are treated with standard oxygen delivered through nasal cannula, face mask or non-rebreathing reservoir</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-flow oxygen group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are treated with high-flow nasal cannula oxygen continuously applied via large-bore nasal prongs with a gas flow rate of 50 L/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-flow oxygen</intervention_name>
    <description>HFNC is continuously applied via large-bore nasal prongs with a gas flow rate of 50 L/min and a FiO2 adjusted to maintain a pulse oxymetry at least 92%</description>
    <arm_group_label>High-flow oxygen group</arm_group_label>
    <other_name>High-flow nasal cannula oxygen therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard oxygen</intervention_name>
    <description>nasal cannula, face mask or non-rebreathing reservoir mask</description>
    <arm_group_label>standard oxygen group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  de novo acute respiratory failure cowith the following criteria: a respiratory rate &gt;
             25 b/min, or signs of increased work of breathing.

        Main exclusion Criteria:

          -  cardiogenic pulmonary edema,

          -  acute exacerbation of chronic lung disease, respiratory acidosis (pH &lt; 7.35 and PaCO2
             &gt; 50 mm Hg),

          -  hemodynamic instability

          -  Glasgow Coma Scale score of 12 points or less,

          -  an urgent need for endotracheal intubation,
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean MACE, MD</last_name>
    <role>Study Director</role>
    <affiliation>CHG de Niort, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHG de Niort</name>
      <address>
        <city>Niort</city>
        <zip>79000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>February 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>February 26, 2018</last_update_submitted>
  <last_update_submitted_qc>February 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

